Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! It mainly consists of two types of cannabinoid receptors (CB1 and CB2). These receptors are built to interact with endocannabinoids (cannabinoids naturally produced by the brain). The endocannabinoid system is essentially the system that processes cannabinoids introduced into the body.

Pets 45

Pets Data CBD Cannabinoids 45

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. TSC is typically diagnosed in childhood. (5)

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. Dr. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

OCTOBER 21, 2021

More than likely, the effects of cannabinoids like CBD and THC are altered during the ketogenic diet, but unfortunately there has been very little research on this topic. This would hypothetically correlate with the altered effects of cannabinoids like THC and CBD, but the study did not look at that. As per usual, more data is needed.

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Implement research findings by consulting experts and translating data into practical actions. Consider consulting with experts in the field to better understand and interpret the research data.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Cheri

APRIL 1, 2022

In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy. We know that cannabinoids like THC and CBD are fat soluable. Not everyone encounters this annoying condition, but many people starting a keto diet do. Read more here.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

NORML

AUGUST 26, 2019

These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.]. The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. It removed qualifying conditions altogether.

Marijuana 208

Marijuana Legalization Programs Oil 208

The Cannigma

SEPTEMBER 15, 2022

As our body of research expands, new avenues of potential treatment emerge for conditions that were previously overlooked. People with autism often have comorbid diagnoses such as anxiety, depression, sleep disturbances, ADHD, epilepsy, allergies, autoimmune conditions, and gastrointestinal conditions. Type I – High THC.

Terpenes 91

Terpenes Strains Sleep THC 91

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. UNDERSTANDING THE BENEFITS OF DIFFERENT CANNABINOIDS. 3%), resulting in very minimal psychoactive stimulation.

CBD 56

CBD Cannabinoids Chronic Pain Epilepsy 56

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). What is medical marijuana? Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

The Cannigma

JUNE 29, 2021

Chemotypes : Types of cannabis that are grouped by their most abundant cannabinoid. Chemovars: Types of cannabis which are loosely defined and grouped, based on at least one or two of the most abundant cannabinoids and two-to-four main terpenes. 10% THC and 30% THC plants could both be Type I, as long as THC is the major cannabinoid).

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Healer

JUNE 28, 2019

Cannabinoids have been shown to reduce the intensity of pain, including inflammatory pain, neuropathic pain, and cancer pain. Cannabinoids reduce spasticity and the pain associated with muscle spasm. In certain situations, cannabinoids can increase the intensity of acute pain. Nabiximols (Nabiximols is the U.S.

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. One isolated study indicates some potential efficacy for an oral cannabinoid /terpene combination in ADHD.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Healer

JANUARY 17, 2022

Cannabigerol (CBG) is one of the 100+ cannabinoids found in cannabis and hemp plants. The most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there’s growing interest in the potential benefits of CBG, which has only recently become available in significant potencies.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Healer

JANUARY 17, 2022

Cannabigerol (CBG) is one of the 100+ cannabinoids found in cannabis and hemp plants. The most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there’s growing interest in the potential benefits of CBG, which has only recently become available in significant potencies.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Cannigma

SEPTEMBER 13, 2021

Also in 2020, Israel surpassed Germany as the world’s largest importer of medical cannabis flower, according to data from Israel’s online Cannabis Magazine. Most notably, scientist Raphael Mechoualm of Hebrew University of Jeruslaem, is credited with isolating tetrahydrocannabinol (THC), as well the cannabinoid 2-AG and anandamide.

Legalization 97

Legalization Decriminalization Patients Cannabis 97

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 Gastrointestinal conditions. Food poisoning.

THC 52

THC CBD Treatment Cannabinoids 52

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

APRIL 4, 2019

Further there is a growing body of evidence that various forms of cannabis could help in the treatment of epilepsy and seizures, post-traumatic stress disorder (PTSD), glaucoma, dementia, Alzheimers, autism, fibromyalgia and a range of auto-immune diseases.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Hair analysis was conducted to confirm the presence of cannabinoids.

Patients 49

Patients Marijuana Epilepsy Treatment 49

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Furthermore, cannabinoids treat these symptoms as the doctors either do chemotherapy or prescribe antivirals for the HIV. Approved Cannabinoid-Based Medications. They take prescription cannabinoids in pill or liquid form.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64